IP Library Granted Patent US 12,529,007
Granted Patent B2
US 12,529,007 · App. 18/189,079 · Granted Jan 20, 2026

Lipid comprising docosapentaenoic

Inventors: James Robertson Petrie (Goulburn, AU); Surinder Pai Singh (Downer, AU); Pushkar Shrestha (Lawson, AU); Jason Timothy McAllister (Portarlington, AU); Robert Charles de Feyter (Monash, AU); Malcolm David Devine (Vernon, CA)
Assignees: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION; GRAINS RESEARCH AND DEVELOPMENT CORPORATION; NUSEED NUTRITIONAL PTY LTD.
C11B1/10A23D9/00A61K31/20A61K31/201A61K31/202A61K31/231A61K31/232A61K36/31C07C69/587C11B3/001C11C3/02C12N15/8247A61K2236/00A61K2236/333
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,529,007
App. No.
18/189,079
Granted
Jan 20, 2026
Kind
B2
Abstract

The present invention relates to extracted plant lipid or microbial lipid comprising docosapentaenoic acid, and processes for producing the extracted lipid.

Claims (11)

1 . Oilseed plant seedoil which is Brassica napus or Camelina sativa seedoil obtained from seed harvested from a population of at least 3,000 Brassica napus or Camelina sativa , respectively, plants grown in a field, the seedoil comprising a total fatty acid content which comprises fatty acids in an esterified form, the total fatty acid content comprising oleic acid, palmitic acid, ω6 polyunsaturated fatty acids which comprise linoleic acid (LA) and γ-linolenic acid (GLA), 03 polyunsaturated fatty acids which comprise α-linolenic acid (ALA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), stearidonic acid (SDA) and eicosatetraenoic acid (ETA), wherein the level of palmitic acid in the total fatty acid content of the seedoil is between 2% and 16% by weight, wherein myristic acid (C14: 0) is either absent or is present in the seedoil at a level of less than 1% by weight of the total fatty acid content of the seedoil, and wherein at least 70% of the DPA esterified in the form of triacylglycerols (TAG) in the seedoil is in the sn-1 or sn-3 position of the TAG.

2 . The seedoil of claim 1 , wherein the seedoil is obtained from seed harvested from a population of at least 2,000,000 Brassica napus or Camelina sativa plants grown in a field.

3 . The seedoil of claim 1 , wherein the SDA, ETA, EPA and DPA are each present at a level in the total fatty acid content, each level being expressed as a percentage of the total fatty acid content, whereby the sum of the percentages for ETA, EPA and DPA divided by the sum of the percentages for SDA, ETA, EPA and DPA, expressed as a percentage, is at least 75%.

4 . The seedoil of claim 1 , wherein a level of GLA of less than 4% by weight is present in the total fatty acid content of the seedoil.

5 . The seedoil of claim 1 , wherein at least 80% of the DPA esterified in the form of TAG in the seedoil is in the sn-1 or sn-3 position of the TAG.

6 . The seedoil of claim 1 , which has the following features: i) the level of oleic acid in the total fatty acid content of the seedoil is between 1% and 30% by weight, ii) the level of LA in the total fatty acid content of the seedoil is between 4% and 35% by weight, iii) the level of GLA in the total fatty acid content of the seedoil is less than 4% by weight, and iv) a level of total saturated fatty acids of between 4% and 25% by weight is present in the total fatty acid content of the seedoil.

7 . The seedoil of claim 1 , wherein the extracted lipid comprises fatty acid C20:1 at a level of less than 1% by weight of the total fatty acid content.

8 . The seedoil of claim 1 , wherein the extracted lipid comprises a new ω3 fatty acid content in the total ω3 fatty acid content and a new ω6 fatty acid content in the total ω6 fatty acid content, each expressed as a percentage by weight of the total fatty acid content, wherein the ratio of the new ω6 fatty acid content to the new ω3 fatty acid content is less than 0.20.

9 . The seedoil of claim 1 , wherein ALA, SDA, ETA, EPA and DPA are each present at a level in the total fatty acid content, each level being expressed as a percentage by weight of the total fatty acid content, and eicosatrienoic acid (ETrA) is either present or absent in the total fatty acid content, whereby the sum of the percentages for SDA, ETA, EPA, and DPA divided by the sum of the percentages for ALA, SDA, ETrA, ETA, EPA and DPA, expressed as a percentage, is at least 30%.

10 . The seedoil of claim 1 , wherein ETA, EPA and DPA are each present at a level in the total fatty acid content, each level being expressed as a percentage by weight of the total fatty acid content, whereby the sum of the percentages for EPA and DPA divided by the sum of the percentages for ETA, EPA and DPA, expressed as a percentage, is between 75% and 98%.

11 . The seedoil of claim 1 , wherein the seedoil is purified by one or more or all of degumming, deodorising, decolourising, drying and/or fractionating the extracted seedoil.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2023
From: PETRIE, JAMES ROBERTSON; SINGH, SURINDER PAL
To: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Reel/Frame 063150/0935 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2023
From: SHRESTHA, PUSHKAR; DE FEYTER, ROBERT CHARLES
To: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Reel/Frame 063150/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2023
From: DEVINE, MALCOLM DAVID
To: CROOKEDHOLM PARTNERS INC.
Reel/Frame 063150/0977 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2023
From: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
To: NUSEED PTY LTD.; GRAINS RESEARCH AND DEVELOPMENT CORPORATION; COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Reel/Frame 063151/0061 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2023
From: MCALLISTER, JASON TIMOTHY
To: NUSEED PTY LTD.
Reel/Frame 063151/0069 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2023
From: CROOKEDHOLM PARTNERS INC.
To: NUFARM AGRICULTURAL INC.
Reel/Frame 063151/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2023
From: NUSEED PTY LTD.
To: NUSEED NUTRITIONAL AUSTRALIA PTY LTD
Reel/Frame 063151/0097 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2023
From: NUFARM AGRICULTURAL INC.
To: NUSEED PTY LTD.
Reel/Frame 063151/0149 →
Priority Claims (2)
AU 2014902471 · Jun 27, 2014 · national
AR 20140104761 · Dec 18, 2014 · national
Continuity (6)
Continuation 16146469 · Sep 28, 2018
Continuation 15617642 · Jun 8, 2017
Continuation 14743531 · Jun 18, 2015
Continuation In Part PCTAU2014050433 · Dec 18, 2014
Continuation In Part 14575756 · Dec 18, 2014
Related Publication 20230219879A1 · Jul 13, 2023
References Cited (42)
US 9718759B2 · Petrie · 2017 [cited by examiner]
US 9725399B2 · Petrie · 2017 [cited by examiner]
US 10125084B2 · Petrie · 2018 [cited by examiner]
US 11623911B2 · Petrie · 2023 [cited by examiner]
Aug. 1, 2022 Response to Jun. 3, 2022 Office Action filed in connection with Philippines Patent Application No. 1-2016-502586. [cited by applicant]
Sep. 12, 2022 Response to May 11, 2022 Examiner's Report filed in connection with Canadian Patent Application No. 2,953,008. [cited by applicant]
Aug. 29, 2022 Response to Feb. 18, 2022 Communication pursuant to Article 94(3) filed in connection with European Patent Application No. 15811918.0. [cited by applicant]
Nov. 9, 2022 Examiner's Report issued in connection with Canadian Patent Application No. 2,953,008. [cited by applicant]
Nov. 7, 2022 Written Opinion issued in connection with Chilean Patent Application No. 202001535 including English language translation thereof. [cited by applicant]
Dec. 22, 2022 Written Opinion issued in connection with Chilean Patent Application No. 201603351 including English language translation thereof. [cited by applicant]
Dec. 26, 2022 Office Action issued in connection with Eurasian Patent Application 202092987 No. (Divisional of EA 037184) including English language translation thereof. [cited by applicant]
Mar. 16, 2023 Examination Report issued in connection with New Zealand Patent Application No. 727514. [cited by applicant]
May 12, 2023 Examination Report issued in connection with Canadian Patent Application No. 2,953,008. [cited by applicant]
May 29, 2023 Written Opinion issued in connection with Chilean Patent Application No. 201603351 including English language translation thereof. [cited by applicant]
Jun. 26, 2023 First Office Action issued in connection with Chinese patent application 202111259171.2 (Divisional of CN ZL201510342019) including English language translation thereof. [cited by applicant]
Sep. 11, 2023 Response to May 12, 2023 Examination Report filed in connection with Canadian Patent Application No. 2,953,008. [cited by applicant]
Mar. 15, 2024 Examination Report issued in connection with Canadian Patent Application No. 3,228,580. [cited by applicant]
Mar. 15, 2024 Office Action issued in connection with Japanese Patent Application No. 2023-017919 including English language translation thereof. [cited by applicant]
Jul. 15, 2024 Response to Mar. 15, 2024 Examination Report filed in connection with Canadian Patent Application No. 3,228,580. [cited by applicant]
Jul. 12, 2023 Examination Report issued in connection with Australian Patent Application No. 2020203743. [cited by applicant]
Jul. 2, 2024 Response to Jul. 12, 2023 Examination Report filed in connection with Australian Patent Application No. 2020203743. [cited by applicant]
Jul. 4, 2024 Examination Report issued in connection with Australian Patent Application No. 2020203743. [cited by applicant]
Jul. 9, 2024 Response to Jul. 4, 2024 Examination Report filed in connection with Australian Patent Application No. 2020203743. [cited by applicant]
Jul. 9, 2024 Examination Report issued in connection with Australian Patent Application No. 2020203743. [cited by applicant]
Jul. 10, 2024 Response to Jul. 9, 2024 Examination Report filed in connection with Australian Patent Application No. 2020203743. [cited by applicant]
Sep. 10, 2024 Office Action issued in connection with Japanese Patent Application No. 2023-017919 including English language translation thereof. [cited by applicant]
Nov. 29, 2024 Office Action issued in connection with Chinese Patent Application No. 202111259171.2 (Divisional of CN ZL201510342019.9) including English language translation thereof. [cited by applicant]
First Information Disclosure Statement Substitute Form PTO-1449 submitted Jul. 31, 2019 and initialed by Examiner on Oct. 8, 2019 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Second Information Disclosure Statement Substitute Form PTO-1449 submitted Jul. 31, 2019 and initialed by Examiner on Oct. 8, 2019 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Third Information Disclosure Statement Substitute Form PTO-1449 submitted Aug. 12, 2019 and initialed by Examiner on Oct. 8, 2019 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Fourth Information Disclosure Statement Substitute Form PTO-1449 submitted Feb. 4, 2020 and initialed by Examiner on Feb. 24, 2020 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Fifth Information Disclosure Statement Substitute Form PTO-1449 submitted Feb. 13, 2020 and initialed by Examiner on Feb. 24, 2020 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Sixth Information Disclosure Statement Substitute Form PTO-1449 submitted Mar. 11, 2020 and initialed by Examiner on Mar. 17, 2020 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Seventh Information Disclosure Statement Substitute Form PTO-1449 submitted Mar. 13, 2020 and initialed by Examiner on Mar. 17, 2020 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Eighth Information Disclosure Statement Substitute Form PTO-1449 submitted Jun. 5, 2020 and initialed by Examiner on Jun. 23, 2020 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Ninth Information Disclosure Statement Substitute Form PTO-1449 submitted Jun. 18, 2020 and initialed by Examiner on Jun. 23, 2020 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Tenth Information Disclosure Statement Substitute Form PTO-1449 submitted Sep. 4, 2020 and initialed by Examiner on Sep. 24, 2020 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Eleventh Information Disclosure Statement Substitute Form PTO-1449 submitted Feb. 8, 2021 and initialed by Examiner on Mar. 31, 2021 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Twelfth Information Disclosure Statement Substitute Form PTO-1449 submitted Jul. 6, 2021 and initialed by Examiner on Oct. 20, 2021 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Thirteenth Information Disclosure Statement Substitute Form PTO-1449 submitted Jan. 31, 2022 and initialed by Examiner on Feb. 8, 2022 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Fourteenth Information Disclosure Statement Substitute Form PTO-1449 submitted Aug. 10, 2022 and initialed by Examiner on Dec. 2, 2022 in connection with U.S. Appl. No. 16/146,469. [cited by applicant]
Jul. 18, 2025 Office Action issued in connection with Canadian Patent Application No. 3,228,580. [cited by applicant]